Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cardurion Pharmaceuticals
Biotech
Cardio-focused Cardurion raises hearty $260M series B
Cardurion plans to harness the fresh funds to support later-stage trials of their two leading first-in-class candidates and acquire other assets.
Darren Incorvaia
Jul 16, 2024 3:47pm
Takeda-backed cardiovascular biotech nabs $300M from Bain
Oct 27, 2021 12:05pm
Greene joins Sage as CEO—Chutes & Ladders
Dec 18, 2020 9:30am
Cardurion taps Takeda veteran Morabito as CMO—Chutes & Ladders
Jul 10, 2020 9:30am
Cardurion nabs Takeda plasma therapy R&D chief as new CMO
Jul 10, 2020 8:10am
Mylan's Coury steps into exec chairman role—Chutes & Ladders
Apr 17, 2020 9:30am
